... are discussions hosted and/or organized by UNAIDS on pertinent HIV science issues and the HIV response.

Principal investigator Richard Hayes and colleagues Virgina Bond and Sarah Fidler will be presenting findings from initial surveys of the HPTN 071 (PopART) study on 20th June, from 13h30 till 15h00 (CEST) at UNAIDS in Geneva. PopART or Population Effects of Antiretroviral Therapy to Reduce HIV Transmission is a research study that will determine the impact of a combination package of HIV prevention activities on community-level HIV incidence.  The study is currently being conducted in 21 communities inhe Western Cape of South Africa, and in Zambia and covers a population of 1.2 million people. Due to funding clearance issues, this briefing was only webcast to UNAIDS Staff and is accessible here.

UNAIDS together with WHO organized a seminar HIV Testing 2014: An update on access, ethics, human rights and quality of HIV testing and counselling at the Kofi A Annan Conference Room, UNAIDS/WHO premises in Geneva from 12:30-14:00 (CET) on 10th January.

Dr Carla Makhlouf Obermeyer was keynote speaker.  Dr Obermeyer is Research Professor and Director of the Center for Research on Population and Health at the American University of Beirut. Prior to joining AUB, she was Scientist in the Department of HIV at WHO, and a faculty member in the Department of Population and International Health at Harvard. She has led a number of multi-site research projects, including the MATCH (Multi-country African Testing and Counselling for HIV) study. Dr Obermeyer has published over 100 articles and four books on a number of international health topics.

Presentations were also made by WHO colleagues.

Tranexamic acid saves lives in trauma patients, by reducing the needs for transfusion.  So it should prevent HIV infections. According to Professor Ian Roberts and his team, tranexamic acid is also more cost-effective than antiretrovirals .  Yet it is not widely used in most countries.

What steps are needed to introduce a cheap, generic drug into routine health care in resource limited settings?

On 21st October, Science now had a discussion on Tranexamic acid in trauma care which dealt with the use of this generic drug to prevent bleeding, thus avoiding HIV acquisition risk via blood transfusion. 

UNAIDS Science now with WHO HIV Knowledge Seminars presented a discussion on The HIV cure agenda: where are we now? from 14h00 to 15h30 (CEST) on Monday, 30 September 2013 at Room 46025 of the UNAIDS/WHO D Building in Geneva.   A video recording of the seminar on WebEx is found at this link (https://who-meeting.webex.com/who-meeting/ldr.php?AT=pb&SP=MC&rID=24160232&rKey=A10BA14F021157C3).

Presentations were made by colleagues from both organizations. 

Professor Sharon R. Lewin, one of the world’s leading AIDS researchers, co-heading the Centre of Biomedical Research, Burnett Institute, and Director of the Department of Infectious Diseases at the Alfred Hospital and Monash University was the guest at the townhall meeting in UNAIDS Geneva on 14th May.

Professor Lewin visited UNAIDS Geneva in her capacity as Co-chair of AIDS2014 Conference Coordinating Committee. She gave a presentation on her research, work under way on the “Towards an HIV Cure” strategy and preparations for AIDS2014 in Melbourne.

UNAIDS Science now hosted a discussion on Paediatric HIV Treatment Access. The discussion informed: the current state of paediatric HIV treatment and care; paediatric formulations in the market; opportunities and challenges in accessing treatment; and improving access to paediatric ARVs.

Presentations were made by colleagues from WHO, UNITAID, UNICEF and UNAIDS.

A seminar co-organized by UNAIDS Science now and the WHO HIV Knowledge Seminars, occurred on 25 March 2013, between 14h00-16h00 at the Kofi A Annan Conference Room of the UNAIDS/WHO D building in Geneva. The seminar was webcast live and a recording is found here.

Topics include: Functional Cure of infant, EFV exposure during pregnancy, TDF use in children, New HCV treatments, Malawi B+ experience, Home oral testing and initiation of ARVs, Integrated care in ANC and effect on cascade, Swaziland  study (ICAP and CDC)

The main presenters of this discussion were Dr Kevin O’Reilly from WHO and Professor Jean-Michel Molina, the project principal investigator of the ANRS-funded Ipergay Trial.  Dr O’Reilly presented the current evidence on PrEP, whereas Prof Molina presented the Ipergay Trial.  Comments on ethical considerations and views from the community were made by UNAIDS colleagues Jason Sigurdson and Kate Thomson, respectively. Dr. Stefano Vella from the L'Istituto Superiore di Sanità (ISS) in Rome chaired the discussion for UNAIDS.